ETFs7 months ago
Can Eli Lilly ETFs Rise Following Alzheimer’s Drug Approval?
On June 10, the FDA’s Peripheral and Central Nervous System (PCNS) Drugs Advisory Committee voted 11-0, unanimously recommending approval of the Elie LillyLLY’s Alzheimer’s drug, donanemab....
